Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TG Therapeutics Inc (NASDAQ:TGTX)

5.83
Delayed Data
As of Jul 22
 -0.21 / -3.48%
Today’s Change
5.61
Today|||52-Week Range
18.60
-51.13%
Year-to-Date

Today’s Trading

Previous close6.04
Today’s open6.04
Day’s range5.77 - 6.07
Volume250,336
Average volume (3 months)408,418
Market cap$316.8M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+15.85%
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,573.69
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...+0.02+0.23%
VSARVersartis Inc-0.04-0.36%
SVASinovac Biotech Ltd+0.01+0.17%
NLNKNewLink Genetics Cor...+0.14+1.29%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$152.4K
Annual profit (last year)-$62.9M
Net profit margin-41,310.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
CFO, Secretary, Treasurer &
CAO
Sean A. Power
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs